Kalça gelişimsel çıkığı'nın  kapalı veya açık redüksiyon ile tedavisi sonrası Koksa Magna: Süreç veya sekel mi?

Aslan, Ahmet

doi:10.30565/medalanya.593576

Acta Medica Alanya

2019

DOI: 10.30565/medalanya.593576

|View full text |Cite

Kalça gelişimsel çıkığı'nın kapalı veya açık redüksiyon ile tedavisi sonrası Koksa Magna: Süreç veya sekel mi?

Ahmet Aslan

Abstract: Amaç:Bu çalışmada kapalı redüksiyon (KR) ya da açık redüksiyon (AR) ile tedavi edilen tek taraflı Gelişimsel Kalça Displazisi (GKD) olgularının takiplerinde görülen, Koksa Magna (KM) sıklığının belirlenmesi ve etkileyen faktörlerin araştırılması amaçlandı. Yöntem: Hastalar retrospektif olarak iki gruba ayrıldı. Grup-1: Genel anestezi altında kapalı redüksiyon (KR) ve pelvipedal alçı yapılan olgulardan oluşuyordu. Grup-2: Medial Açık redüksiyon (AR) ve pelvipedal alçı uygulanan olgulardan oluşuyordu. Son kontro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Coxa Magna following treatment of developmental dysplasia of the hip: investigation for associated potential factors

Topak

Aslan²,

Yorgancigil

2022

Journal of Pediatric Orthopaedics B

Self Cite

View full text Add to dashboard Cite

Coxa Magna (CM) is defined as a condition in which the horizontal (transverse) diameter of the femoral head is larger on the affected side than on the intact side. CM can occur as a manifestation of avascular necrosis (AVN) following treatment for the developmental dysplasia of the hip (DDH). Alternatively, it can also be secondary to other hip disorders, such as Perthes’ disease. This study aimed to determine the prevalence and indicators of CM and AVN of the femoral head that can be detected during follow-up in patients with unilateral DDH treated with closed reduction (CR) or open reduction (OR) surgery. The files of 143 patients treated for unilateral DDH between January 1997 and December 2017 were reviewed retrospectively. A total of 104 patients, including Group 1 (n = 49) patients who underwent CR under general anesthesia and Group 2 (n = 55) patients who underwent OR were included in the study. CM; It was considered as the case where the femoral head was 15% or more larger than the intact side. A total of 104 patients were followed up for 77.27 ± 13.96 months, with a mean age of 15.43 ± 7.76 months. When Group 1 and Group 2 were compared, there was no statistical difference in terms of sex, side, adductor tenotomy, and AVN (P > 0.05). CM developed in 22.4% (n = 11) of the patients in Group 1 and in 49.1% (n = 27) in Group 2, and the difference was statistically significant (P = 0.008). When the effect of independent variables on the development of CM is evaluated with the multivariate logistic regression model, the risk of developing CM is 3474 times higher in those who underwent iliopsoas tenotomy compared with those who did not. The primary outcome of this study is that CM is more frequent in patients treated with OR for DDH. CM may be a nonpathological condition that occurs in connection with iliopsoas tenotomy or surgical treatment. Prospective studies with a larger number of cases, designed to minimize confounding factors, are required.

show abstract

Coxa Magna following treatment of developmental dysplasia of the hip: investigation for associated potential factors

Topak

Aslan²,

Yorgancigil

2022

Journal of Pediatric Orthopaedics B

Self Cite

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Kalça gelişimsel çıkığı'nın kapalı veya açık redüksiyon ile tedavisi sonrası Koksa Magna: Süreç veya sekel mi?

Cited by 1 publication

References 20 publications

Coxa Magna following treatment of developmental dysplasia of the hip: investigation for associated potential factors

Coxa Magna following treatment of developmental dysplasia of the hip: investigation for associated potential factors

Contact Info

Product

Resources

About